| [1] |
John CS, Vilner BJ,GuldeM E, et al.Synthesis and pharmacological characterization of 4-[125I]-N-(n-Benzylpiperidin-4yl)-4-iodobenzamide:A high affinity σ receptor ligand for potential imaging of breast cancer[J]. Cancer Res, 1995,55:3022~3027.
|
| [2] |
Mach RH,Smith CR,Whirrett BR,et al.σ2 receptor as potential biom arkers of proliferation in breast cancer[J]. Cancer Res, 1997,57:156~161.
|
| [3] |
John CS, Lim BB, Vilner BJ, et al.Substituted halogenated ary lsulfonamides:A new class of σ receptor binding tumorimaging agents[J]. J Med Chem,1998, 41:2445~2450.
|
| [4] |
Seth P, Fei Y J,Huang FH, et al.Cloning and functional characterization of a sigmareceptor from rat brain[J]. JN eurochem,1998, 70:922~931.
|
| [5] |
Vilder BJ,John CS and Bowen WD.Sigma-1 and Sigma-2 receptor are expressed in a wide variety of human and rodent tumor cell lines[J]. Cancer Res, 1995, 15:408~413.
|
| [6] |
John CS,Gulden ME,Li JH,et al.Synthesis,in vitro binding, and tissue distribution of radio iodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodobenzamide,2-[125I] BP:A potential marker for human prostate tumors[J]. Nucl Med Biol,1998,25:189~194.
|
| [7] |
Watethouse RN, Mardon K and Brien JC. Synthesis and preliminary evaluation of [123I]1-(4-Cyanobenzl)-4-[[(trans-iodopropen-2-yl)oxy]-methyl]piperidine:A novel high affininty sigm a receptor radioligand for SPECT[J]. Nucl Med Biol,1997, 24:45~51.
|
| [8] |
John CS,Bow en WD,Fisher SJ,et al.Synthesis,in vitro pharmacolog ic characterization, and preclinical evaluation of N-[2-(1'-piperdinyl)ethy l]-3-[125I] iodo-4-methoxybenza mide (P[125I]MBA) for imaging breast cancer[J]. Nucl Med Biol,1999, 26:377~382.
|
| [9] |
John CS, Lim BB, Geyer BC, et al.99Tcm-labeled σ-receptor-binding complex:Synthesis,characterization, and specific binding to human ductal breast carcinoma (T47D) cells[J]. Bioconjugate Chem, 1997,8:304~309.
|